The intellectual input of the neuroscientists and trained technical experts, combined with a dedicated phenotyping facility enables:

• The provision of a complete phenotyping service
  
  
• Electrophysiological and pharmacological testing of disease models
  
  
• Drug discrimination/dependence testing
  
  
• Pharmacological screening of potential anxiolytics/anxiogenics, antipsychotic drugs, antidepressants, nootropics/cognitive enhancers, and neuroprotectants
  
  
• Pharmacological screening for agents effective in various disease states, including epilepsy, Parkinson's disease, Alzheimer's disease, dementia, etc.
  
  
• Analgesia assessments
  
  
• The conduct of internationally competitive research with a strong therapeutic focus on neurological and psychiatric conditions
  
  
• Enhancement of the capacity for animal behavioural assessment within Australian neuroscience through collaborative research programs and targeted training programs

We can provide advice for grant applications requiring animal phenotyping.